Form D · Pharmaceuticals
Cardax Pharma, Inc.
Honolulu, HI · CIK 0001579166
Offering snapshot reported Jan 17, 2014 · SEC filing
- Reported sold
- $2.08M Offering amount: $5M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $12K Reported outside-investor minimum
- First sale
- Jan 3, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 17, 2014 | Initial | $2,076,000 | No comparison | 26 | SEC filing |
| Jun 17, 2013 | Initial | $781,170 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $270K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-210330
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Portfolio Advisors Alliance, Inc. | 101680 | Portfolio Advisors Alliance, Inc. · CRD 101860 |
| Agincourt Ltd. | 36661 | Agincourt Ltd. · CRD 36661 |
Source: Form D, filed Jan 17, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank C. Herringer | Director |
| Nicholas Mitsakos | Director |
| David G. Watumull | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2800 Woodlawn Drive Suite 129
Honolulu, HI, 96822
Honolulu, HI, 96822